Clinical study of bone-strengthening pill on the treatment of osteonecrosis of the femoral head

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IIR-17011277

Enrollment

Unknown

Registered

2017-05-02

Start date

1996-03-10

Completion date

Unknown

Last updated

2017-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteonecrosis of the femoral head

Interventions

experimental group:bone-strengthening pill

control group:Compound Danshen Tablet

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients aged 18 to 70 years old; osteonecrosis of the femoral head

Exclusion criteria

Exclusion criteria: Complicated with liver, kidney and cardiovascular and cerebrovascular diseases, psychiatric patients, the use of hormone treatment of other diseases. Avascular necrosis of the femoral head caused by bone tumors and hematological diseases. Patients with the disease being treated with other drugs. Not according to the prescribed medication, can not determine the efficacy or data is not congruent affect the efficacy or safety judge.

Design outcomes

Primary

Measure	Time frame
Bone images;	—

Secondary

Measure	Time frame
Pain, durere, function;	—

Countries

China

Contacts

Public ContactWang Lulin

Department of Orthopedics, Beijing Jianxing Traditional Chinese Medicine Hospital

wanglulin88@126.com+86 13901101006

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026